Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

Stefano Omboni, Ettore Malacco, Jean-Michel Mallion, Massimo Volpe
  • Clinical Interventions in Aging, October 2015, Dove Medical Press
  • DOI: 10.2147/cia.s88195
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
open access logoRead Publication


The following have contributed to this page: Stefano Omboni